Harrow Health, Inc. (HROW) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Harrow Health, Inc. on November 14, 2022. The filing serves to announce the Company's financial results for the period ended September 30, 2022, and provides an update on recent corporate events. The report includes a press release and a letter to stockholders as Exhibits 99.1 and 99.2.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the attached Exhibits 99.1 and 99.2, which are not included in the source text.
Material Changes
The filing indicates that material information regarding the period ended September 30, 2022, and recent corporate events is contained within the furnished exhibits. No specific quantitative changes versus prior periods are detailed in the main body of this 8-K text.
Guidance, Outlook, and Risks
The Company explicitly states that the information furnished under Item 2.02, including the exhibits, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that Section. Furthermore, the Company does not assume any obligation to update the information provided in this report or the exhibits in the future.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific financial results for the period ended September 30, 2022.
- Review Exhibit 99.2 (Letter to Stockholders) for details on recent corporate events and management commentary.
- Verify the status of the 8.625% Senior Notes due 2026 (HROWL) listed as registered securities.
- Note that the Company has disclaimed any obligation to update the information provided in this filing.